Autosomal recessive congenital ichthyosis 5
MONDO:0011485An autosomal recessive congenital ichthyosis characterized by fine white or greyish-white scales, hyperkeratosis, moderate acanthosis, and moderate parakeratosis that has material basis in homozygous mutation in the CYP4F22 gene on chromosome 19p13.
Also known as: ARCI5, autosomal recessive congenital ichthyosis 5, autosomal recessive congenital ichthyosis type 5, ichthyosis, congenital, autosomal recessive type 5, LI3, formerly, NNCI, ichthyosis congenita 3, ichthyosis congenita III
19 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
VR headsets tested as a possible treatment for blindness
Disease control TerminatedThis study tested whether using a virtual reality headset for one-hour sessions could help regenerate damaged optic nerves and improve vision in people with glaucoma or other retinal diseases. The idea came from promising results in rodents. However, the trial was terminated earl…
Phase: NA • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Promising ichthyosis drug trial stalls after just 5 patients
Disease control TerminatedThis study tested a drug called imsidolimab (ANB019) in people with ichthyosis, a condition that causes dry, scaly, and red skin. The trial aimed to see if the drug could improve skin symptoms compared to a placebo. However, the study was stopped early and only enrolled 5 partici…
Phase: PHASE2 • Sponsor: Vanda Pharmaceuticals • Aim: Disease control
Last updated Jun 26, 2026 17:50 UTC